Abeona Therapeutics Inc. (ABEO) 当前追踪市盈率 (P/E) 为 3.6, 前瞻市盈率为 40.0. 追踪盈利收益率为 27.43%, 前瞻盈利收益率 2.50%. PEG 0.27 (Peter Lynch 低估标准 ≤1.0). 格雷厄姆数为 $9.54.
本页证实的标准:
SharesGrow 综合评分： 74/100 其中 4/7 项标准通过。
| Year | P/E (TTM) | PEG 比率 | P/B 比率 | P/S 比率 | 股息收益率 |
|---|---|---|---|---|---|
| 2016 | -7.6 | -0.35 | 1.67 | 186.44 | - |
| 2017 | -24.2 | -9.66 | 3.88 | 788.24 | - |
| 2018 | -6.0 | -0.07 | 2.53 | 113.18 | - |
| 2019 | -2.2 | -0.08 | 0.92 | 0.00 | - |
| 2020 | -1.7 | 0.04 | 1.42 | 14.55 | - |
| 2021 | -0.4 | 0.07 | 0.79 | 11.16 | - |
| 2022 | -0.6 | 0.01 | 0.90 | 17.13 | - |
| 2023 | -2.0 | 0.04 | 7.22 | 30.60 | - |
| 2024 | -3.6 | 0.09 | 5.19 | 0.00 | - |
| 2025 | 3.9 | -0.02 | 1.75 | 47.95 | - |
| Year | EPS（稀释） | 营收 | 净利润 | 净利润率 |
|---|---|---|---|---|
| 2016 | $-16.00 | $889K | $-21.87M | -2460.4% |
| 2017 | $-16.40 | $837K | $-27.32M | -3263.9% |
| 2018 | $-29.81 | $3M | $-56.67M | -1890.3% |
| 2019 | $-38.07 | $0.00 | $-76.28M | - |
| 2020 | $-22.75 | $10M | $-84.23M | -842.3% |
| 2021 | $-21.50 | $3M | $-84.94M | -2831.2% |
| 2022 | $-4.05 | $1.41M | $-31.81M | -2249.6% |
| 2023 | $-2.53 | $3.5M | $-54.19M | -1548.2% |
| 2024 | $-1.55 | $0.00 | $-63.73M | - |
| 2025 | $1.01 | $5.82M | $71.18M | 1223.1% |
| Year | EPS（平均） | EPS 范围 | 营收（平均） | 营收范围 | 分析师人数 |
|---|---|---|---|---|---|
| 2026 | $-0.74 | $-1.40 – $0.09 | $64.15M | $32.22M – $89.85M | 4 |
| 2027 | $0.14 | $-0.12 – $0.47 | $148.87M | $90.65M – $186.09M | 4 |
| 2028 | $1.14 | $0.64 – $2.20 | $245.06M | $241.53M – $248.59M | 4 |
| 2029 | $1.60 | $0.79 – $2.28 | $296.84M | $181.78M – $393.44M | 2 |
| 2030 | $2.06 | $1.02 – $2.93 | $356.62M | $218.39M – $472.68M | 2 |
